Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (281-290 of 706) with videos related to

Pageof 71
Sort By:
American Heart Journal|August 7, 2019
Simulation of impact on cardiovascular events due to lipid-lowering therapy intensification in a population with atherosclerotic cardiovascular diseaseChristopher P Cannon, Irfan Khan, Alexa C Klimchak, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 30, 2021
Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndromeXavier Rossello, João Pedro Ferreira, Francisca Caimari, et al.
Journal of the American Heart Association|March 14, 2023
Remote Cardiovascular Hypertension Program Enhanced Blood Pressure Control During the COVID-19 PandemicSimin Gharib Lee, Alexander J Blood, Christopher P Cannon, et al.
Journal of the American College of Cardiology|July 10, 2003
Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trialsC Michael Gibson, Juhana Karha, Sabina A Murphy, et al.
Journal of the American College of Cardiology|June 6, 2006
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 studyBenjamin M Scirica, David A Morrow, Christopher P Cannon, et al.
The American Journal of Cardiology|January 27, 2009
Relation of death within 90 days of non-ST-elevation acute coronary syndromes to variability in electrocardiographic morphologyZeeshan Syed, Benjamin M Scirica, Satishkumar Mohanavelu, et al.
American Heart Journal|February 16, 2010
Are quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitalsYing Xian, Wenqin Pan, Eric D Peterson, et al.
Atherosclerosis|June 18, 2017
Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid managementG B John Mancini, Milan Gupta, Michelle Tsigoulis, et al.
Journal of Thrombosis and Thrombolysis|October 2, 2002
The smoker's paradox: insights from the angiographic substudies of the TIMI trialsBrad G Angeja, Sarah Kermgard, Michael S Chen, et al.
Journal of the American Heart Association|October 12, 2017
Short Sleep Duration, Obstructive Sleep Apnea, Shiftwork, and the Risk of Adverse Cardiovascular Events in Patients After an Acute Coronary SyndromeLaura K Barger, Shantha M W Rajaratnam, Christopher P Cannon, et al.
Pageof 71

Showing results (281-290 of 706) with videos related to

Sort By:
Pageof 71
American Heart Journal|August 7, 2019
Simulation of impact on cardiovascular events due to lipid-lowering therapy intensification in a population with atherosclerotic cardiovascular diseaseChristopher P Cannon, Irfan Khan, Alexa C Klimchak, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 30, 2021
Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndromeXavier Rossello, João Pedro Ferreira, Francisca Caimari, et al.
Journal of the American Heart Association|March 14, 2023
Remote Cardiovascular Hypertension Program Enhanced Blood Pressure Control During the COVID-19 PandemicSimin Gharib Lee, Alexander J Blood, Christopher P Cannon, et al.
Journal of the American College of Cardiology|July 10, 2003
Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trialsC Michael Gibson, Juhana Karha, Sabina A Murphy, et al.
Journal of the American College of Cardiology|June 6, 2006
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 studyBenjamin M Scirica, David A Morrow, Christopher P Cannon, et al.
The American Journal of Cardiology|January 27, 2009
Relation of death within 90 days of non-ST-elevation acute coronary syndromes to variability in electrocardiographic morphologyZeeshan Syed, Benjamin M Scirica, Satishkumar Mohanavelu, et al.
American Heart Journal|February 16, 2010
Are quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitalsYing Xian, Wenqin Pan, Eric D Peterson, et al.
Atherosclerosis|June 18, 2017
Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid managementG B John Mancini, Milan Gupta, Michelle Tsigoulis, et al.
Journal of Thrombosis and Thrombolysis|October 2, 2002
The smoker's paradox: insights from the angiographic substudies of the TIMI trialsBrad G Angeja, Sarah Kermgard, Michael S Chen, et al.
Journal of the American Heart Association|October 12, 2017
Short Sleep Duration, Obstructive Sleep Apnea, Shiftwork, and the Risk of Adverse Cardiovascular Events in Patients After an Acute Coronary SyndromeLaura K Barger, Shantha M W Rajaratnam, Christopher P Cannon, et al.
Pageof 71